Benzinga··Vandana SinghAstraZeneca's Imfinzi Combination Achieves Survival Breakthrough in Bladder Cancer
AstraZeneca's Imfinzi combined with enfortumab vedotin improved survival in cisplatin-ineligible bladder cancer patients in pivotal Phase 3 testing.
AZNPhase 3 trialbladder cancer